Cargando…
Interprovincial Differences in Access to Phosphate Lowering Medication; Implications for Care as Canada Moves Toward a National Pharmacare Program
Autores principales: | Wilson, Tristin E., Holden, Rachel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640798/ https://www.ncbi.nlm.nih.gov/pubmed/38020480 http://dx.doi.org/10.1177/20543581231207467 |
Ejemplares similares
-
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
por: Rawson, Nigel S. B.
Publicado: (2020) -
Towards nationally curated data archives for clinical radiology image
analysis at scale: Learnings from national data collection in response to a
pandemic
por: Cushnan, Dominic, et al.
Publicado: (2021) -
Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
por: Gagnon, Marc-André
Publicado: (2020) -
Access to Scientific Research: The Return on the Taxpayer's Investment
por: Story, S. Drew
Publicado: (2017) -
The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular Diseases
por: Barbour, Sean, et al.
Publicado: (2018)